Literature DB >> 30407258

Irritable bowel syndrome and colonic diverticular disease: overlapping symptoms and overlapping therapeutic approaches.

Rommel Zerpa Alamo1, Eamonn M M Quigley.   

Abstract

PURPOSE OF REVIEW: Irritable bowel syndrome (IBS) is a common symptomatic disorder in the Western world and colonic diverticula are also prevalent; however, relationships between IBS-type symptoms and diverticula have been a source of much debate. Our goal was to reassess these relationships in the light of new data. RECENT
FINDINGS: On removing from consideration clinical scenarios which are directly related to diverticula (i.e., diverticulitis, diverticular hemorrhage, and complications of diverticulitis, such as stricture and fistula), relationships between IBS and diverticula can be seen to revolve around a number of questions. First, are IBS and symptomatic uncomplicated diverticular disease (SUDD) the same condition? Or, in other words is SUDD no more than IBS in an individual who just happens to have diverticula? Although coincident IBS and diverticula inevitably do occur there is some evidence to indicate that SUDD may be somewhat distinctive with SUDD being characterized by more frequent and severe pain. Second, and analogous to interactions between IBS and inflammatory bowel disease or celiac disease, can an episode of acute diverticulitis lead to the de novo development of IBS? There is now epidemiological and pathophysiological evidence to support this occurrence.
SUMMARY: Although relationships between uncomplicated diverticular disease and IBS have been reexamined their status remains unclear. As yet, however, none of the newer concepts related to this relationship have led to new therapeutic approaches in IBS or diverticular disease.

Entities:  

Year:  2019        PMID: 30407258     DOI: 10.1097/MOG.0000000000000499

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  3 in total

Review 1.  Paradigm shift: the Copernican revolution in diverticular disease.

Authors:  Angelo Zullo; Luigi Gatta; Roberto Vassallo; Vincenzo De Francesco; Raffaele Manta; Fabio Monica; Giulia Fiorini; Dino Vaira
Journal:  Ann Gastroenterol       Date:  2019-08-02

Review 2.  Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease.

Authors:  Elisabetta Bretto; Ferdinando D'Amico; Walter Fiore; Antonio Tursi; Silvio Danese
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

3.  Effects of Ellagic Acid on Oxidative Stress Index, Inflammatory Markers and Quality of Life in Patients With Irritable Bowel Syndrome: Randomized Double-blind Clinical Trial.

Authors:  Zahra Mirzaie; Ali Bastani; Ali Akbar Haji-Aghamohammadi; Mohammadreza Rashidi Nooshabadi; Bahman Ahadinezhad; Hossein Khadem Haghighian
Journal:  Clin Nutr Res       Date:  2022-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.